Washington university education department receives $10 million NSF grant

St. Louis, Mo., Sept. 25, 2002- The Department of Education in Arts & Sciences has been awarded a $10 million grant from the National Science Foundation (NSF) to create the St. Louis Center for Inquiry in Science Teaching and Learning (CISTL) at the University.

As one of only ten NSF funded Centers for Learning and Teaching, CISTL will serve as a national model, improving science education through research and researched practice.

Unique to CISTL from the other Centers funded by NSF is the focus on collaboration among various types of institutions supporting science education. CISTL partners include Tyson Research Center, St. Louis Science Center, Saint Louis Zoo, Missouri Botanical Garden, University of Missouri in St. Louis, St. Louis Community College, the Association of Science-Technology Centers and five school districts -- University City, St. Louis Public Schools, Riverview Gardens, Maplewood-Richmond Heights and Kirkwood.

"This is a unique opportunity for the St. Louis community to support and to advance the development of an urban learning alliance in science education that links a major research university to important repositories of scientific knowledge in the community," said William Tate, chair of the Department of Education. "I view this NSF award to Washington University as significant in developing models of excellence in teacher education and doctoral studies in science education that are directly connected to urban communities. This is an exciting moment for Washington University and all involved in this endeavor."

The five-year project officially begins in January 2003, though work on CISTL began with a developmental grant from NSF last year.

"Our primary goal is to improve science learning and teaching across the educational continuum," said Christine Klein, principal investigator and project director for CISTL. This includes pre-service and in-service teachers, staff at local science institutions, doctoral and po

Contact: Neil Schoenherr
Washington University in St. Louis

Page: 1 2

Related biology news :

1. Washington University in St. Louis leads group studying aging process
2. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
3. Washington University in St. Louis plays key role in sequencing moss genome
4. APS awards 55 minority travel fellowships to EB 2004 (April 17-21) in Washington, DC
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Innovative shuttle bus debuts in Washington, D.C.
7. Washington University in St. Louis, Monsanto Co., awarded crop protection patent
8. SARS pre-screening protocol developed for AACR Annual Meeting in Washington, D.C.
9. AACR reschedules annual meeting for July 11-14 in Washington, D.C.
10. Washington-area chemist wins national award for free-radical research
11. Washington Universitys Sarah C. R. Elgin is one of 20 million dollar professors

Post Your Comments:

(Date:7/10/2020)... ... 08, 2020 , ... Overcoming Comparability Issues in Regenerative Medicines ... Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy , ... way to complete one? Will the study comply with all FDA requirements? Understanding ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... (PRWEB) , ... June 30, ... ... expert tissue data insights, today announced that the launch of a new ... along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is ...
(Date:6/28/2020)... , ... June 25, 2020 , ... ... advance photodynamic therapy for treating cancer, today announced the company has entered a ... Park”). The agreement provides Lumeda globally exclusive rights to Roswell Park intellectual ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the premier provider ... Derek Fournier has been appointed CEO and President. Founder and former CEO, David ... , “DeCurtis Corporation has been on an incredible journey for the last twenty ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... innovative CNS therapies, today announced that it has filed an Investigational New Drug ... Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients with ...
Breaking Biology Technology:
Cached News: